Insider · CIK 0001612903

Anderson Thomas

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001612903

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-05-29	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-07-16	ZVRAZEVRA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+10K sh	$6.81	+$68.1K	20,000
2024-05-13	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+39.2K sh	—	—	39,200
2023-09-06	ZVRAZEVRA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+10K sh	$4.88	+$48.8K	10,000
2023-08-07	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+58.8K sh	—	—	58,800
2017-02-06	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+40K sh	—	—	40,000
2016-12-15	Sage Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,900 sh	$8.92	+$16.9K	1,900
2016-12-15	Sage Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−346 sh	$48.99	−$17K	1,554
2016-12-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1,900 sh	—	—	165,138
2016-12-08	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+12.6K sh	—	—	59,500
2016-11-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−10K sh	—	—	167,038
2016-11-15	Sage Therapeutics, Inc.S Sale	See Remarks	SSale	−10K sh	$55.00	−$550K	0
2016-11-15	Sage Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+10K sh	$8.92	+$89.2K	10,000
2016-02-08	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+22.5K sh	—	—	22,500
2015-08-10	Sage Therapeutics, Inc.S Sale	See Remarks	SSale	−1,300 sh	$65.34	−$84.9K	0
2015-08-10	Sage Therapeutics, Inc.S Sale	See Remarks	SSale	−3,480 sh	$67.66	−$235K	2,520
2015-08-10	Sage Therapeutics, Inc.S Sale	See Remarks	SSale	−1,220 sh	$67.14	−$81.9K	1,300
2015-06-08	Sage Therapeutics, Inc.S Sale	See Remarks	SSale	−1,200 sh	$78.56	−$94.3K	6,000
2015-06-08	Sage Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+5,500 sh	$8.92	+$49.1K	11,500
2015-06-08	Sage Therapeutics, Inc.S Sale	See Remarks	SSale	−4,300 sh	$79.95	−$344K	7,200
2015-06-08	Sage Therapeutics, Inc.Stock Options (Right to buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−5,500 sh	—	—	132,169
2015-01-23	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+59.5K sh	—	—	59,500
2014-07-23	Sage Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+6,000 sh	$18.00	+$108K	6,000

Recent filings

Accepted (ET)
Jun 184
Anderson Thomas0001434647-26-000051
SEC(opens sec.gov)
May 304
Anderson Thomas0001437749-25-019044
SEC(opens sec.gov)
Jul 164
Anderson Thomas0001437749-24-022829
SEC(opens sec.gov)
May 154
Anderson Thomas0001437749-24-017174
SEC(opens sec.gov)
Sep 64
Anderson Thomas0001437749-23-025312
SEC(opens sec.gov)
Aug 254
Anderson Thomas0001437749-23-024680
SEC(opens sec.gov)
Feb 84
Sage Therapeutics, Inc.0001562180-17-000574
SEC(opens sec.gov)
Dec 194
Sage Therapeutics, Inc.0001562180-16-003843
SEC(opens sec.gov)
Dec 164
Sage Therapeutics, Inc.0001562180-16-003829
SEC(opens sec.gov)
Nov 284
Sage Therapeutics, Inc.0001562180-16-003622
SEC(opens sec.gov)
Feb 104
Sage Therapeutics, Inc.0001562180-16-001569
SEC(opens sec.gov)
Aug 114
Sage Therapeutics, Inc.0001562180-15-000660
SEC(opens sec.gov)
Jun 84
Sage Therapeutics, Inc.0001562180-15-000467
SEC(opens sec.gov)

Companies

Address

C/O ZEVRA THERAPEUTICS, INC. 101 FEDERAL STREET

BOSTON, MA, 02110